Concepción González-Bello, born in Vigo (Spain), graduated with honors in Chemistry from the University of Santiago de Compostela (Spain) in 1989 and obtained her PhD from the same institution in 1994 under the supervision of Profs. Enrique Guitián and Luis Castedo.
During her doctoral studies, she completed two predoctoral research stays: first at the University of Gent (Belgium, 1991) with Prof. M. Vandewalle and later at the Scripps Research Institute (La Jolla, USA, 1992) with Prof. K. C. Nicolaou. She subsequently undertook a postdoctoral fellowship as an EC-funded researcher at the University of Cambridge (UK) with Prof. Chris Abell (1994–1996). In late 1996, she joined the University of Santiago de Compostela as an Assistant Professor, was promoted to Associate Professor in 2003, and became Full Professor in 2022. In 2011, she joined the CIQUS as a group leader.
She is author of about 120 peer-reviewed scientific articles, 14 book chapters and three European patents (ORCID). She serves as an Academic Editor for “PLOS ONE” (2015-) and Associate Editor for "Frontiers in Pharmacology" (2021-). She is also a member of the International Advisory Board of Advanced Therapeutics (2018-), ACS Omega (2021-), Frontiers in Microbiology (2022-) and previously ChemMedChem (2010-2020).
Since February 2021, she has been Treasurer of the Spanish Royal Society of Chemistry (RSEQ) and, since November 2019, a member of CURES (Comité de Usuarios de la Red Española de Supercomputación).
She served as one of the managers of the Spanish State Research Agency (AEI) in the subarea "Chemical Sciences and Technologies (CTQ)" from 2019 to 2025.
In recognition of her scientific contributions, she was awarded the Ignacio Ribas Medal in 2021 by the Organic Chemistry Group of the Spanish Royal Society of Chemistry (link).